Exodeoxyribonucleases producing 5'-phosphomonoesters (3.1.11)

Full Title

Hydrolases acting on ester bonds (3.1) > Exodeoxyribonucleases producing 5'-phosphomonoesters (3.1.11)

Filing statistics

CPC C12Y 301/11 belongs to the parent subclass C12Y, which recorded 144,590 patent applications worldwide between 2013 and 2023. Annual filings grew from 9,773 in 2013 to 11,938 in 2023 (+22%), peaking at 15,970 applications in 2021. The most active applicants in class C12 are HARVARD UNIVERSITY (8,321 applications), CHINESE ACADEMY OF SCIENCES (7,486 applications) and UNIVERSITY OF CALIFORNIA (7,320 applications).

Source: EPO PATSTAT, worldwide filings

6 direct subcodes

Child Classifications

Navigate with arrow keys, Enter to open

C12Y 301/11001 Exodeoxyribonuclease I (3.1.11.1)
C12Y 301/11002 Exodeoxyribonuclease III (3.1.11.2)
C12Y 301/11003 Exodeoxyribonuclease (lambda-induced) (3.1.11.3)
C12Y 301/11004 Exodeoxyribonuclease (phage SP3-induced)(3.1.11.4)
C12Y 301/11005 Exodeoxyribonuclease V (3.1.11.5)
C12Y 301/11006 Exodeoxyribonuclease VII (3.1.11.6)

Top Applicants

Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT

HARVARD UNIVERSITY US 8,321
CHINESE ACADEMY OF SCIENCES 7,486
UNIVERSITY OF CALIFORNIA US 7,320
REGENERON PHARMACEUTICALS US 5,003
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
UNIVERSITY OF PENNSYLVANIA US 4,213
CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
JIANGNAN UNIVERSITY 3,961
ROCHE CH 3,792
ILLUMINA US 3,692